Biofrontera AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR0.19 |
Market Cap |
EUR342.95 M |
Shares Outstanding |
44.6 M |
Public Float |
25.58 M |
Address |
Hemmelrather Weg 201 Leverkusen Nordrhein-Westfalen 51377 Germany |
Employees | - |
Website | http://biofrontera.com |
Updated | 07/08/2019 |
Biofrontera AG is a biopharmaceutical company, which engages in the development, sale, and distribution of dermatological drugs and medical cosmetics for the care, protection, and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria, and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany. |